CorMedix Inc. (CRMD) Ownership
CRMD ownership summary
as of October 18, 2026- Institutions
- 58.0% of shares outstanding
- Insiders
- 7.61% of shares outstanding
- Shares outstanding
- 77.9M
- Float
- 65.9M shares available to trade
- Short interest
- 20.05% 15.4M shares short
- Days to cover
- 17.97 short interest down 4.8% vs prior month
- Institutions 57.95%
- Insiders 7.61%
- Other investors 34.44%
CRMD top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | BlackRock Inc | 8.11% | 6.3M | $45.9M | +356,536 (+6.0%) | June 30, 2026 |
| 2 | Deep Track Capital, LP | 8.05% | 6.3M | $45.5M | — | June 30, 2026 |
| 3 | Vanguard Capital Management, LLC | 4.02% | 3.1M | $22.8M | +5,419 (+0.2%) | June 30, 2026 |
| 4 | State Street Corp | 2.97% | 2.3M | $16.8M | +125,002 (+5.7%) | June 30, 2026 |
| 5 | Royce & Associates, LP | 2.79% | 2.2M | $15.8M | +288,830 (+15.3%) | June 30, 2026 |
| 6 | Geode Capital Management, LLC | 2.50% | 1.9M | $14.1M | +130,107 (+7.2%) | June 30, 2026 |
| 7 | UBS Group AG | 2.41% | 1.9M | $13.6M | +339,695 (+22.1%) | June 30, 2026 |
| 8 | Oberweis Asset Management Inc | 1.70% | 1.3M | $9.6M | +112,800 (+9.3%) | June 30, 2026 |
| 9 | Alyeska Investment Group, L.P. | 1.09% | 850K | $6.2M | — | June 30, 2026 |
| 10 | Marshall Wace Asset Management Ltd | 1.00% | 780K | $5.7M | +276,570 (+55.0%) | June 30, 2026 |
| 11 | Northern Trust Corp | 0.97% | 756K | $5.5M | +118,747 (+18.6%) | June 30, 2026 |
| 12 | Vanguard Portfolio Management, LLC | 0.91% | 709K | $5.1M | −33,967 (−4.6%) | June 30, 2026 |
| 13 | Pacer Advisors, INC. | 0.81% | 634K | $4.6M | +53,358 (+9.2%) | June 30, 2026 |
| 14 | HRT FINANCIAL LLC | 0.80% | 626K | $4.5M | +333,113 (+113.9%) | June 30, 2026 |
| 15 | Trexquant Investment LP | 0.80% | 624K | $4.5M | +63,160 (+11.3%) | June 30, 2026 |
| 16 | Charles Schwab Investment Management Inc | 0.79% | 618K | $4.5M | +15,206 (+2.5%) | June 30, 2026 |
| 17 | Armistice Capital, LLC | 0.64% | 500K | $3.6M | +500,000 (0.0%) | June 30, 2026 |
| 18 | Vanguard Fiduciary Trust Co | 0.62% | 484K | $3.5M | −21,357 (−4.2%) | June 30, 2026 |
| 19 | The Goldman Sachs Group Inc | 0.60% | 466K | $3.4M | −44,936 (−8.8%) | June 30, 2026 |
| 20 | Hennion & Walsh Asset Management Inc | 0.56% | 439K | $3.2M | +263,618 (+150.6%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 15 holders added 3.0M shares and 3 cut 100K.
CRMD top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 2.86% | 2.2M | $16.2M | — | August 31, 2026 |
| 2 | Avantis US Small Cap Value ETF | 2.75% | 2.1M | $15.6M | +16,584 (+0.8%) | September 30, 2026 |
| 3 | iShares Russell 2000 ETF | 2.50% | 1.9M | $14.1M | −22,464 (−1.1%) | September 30, 2026 |
| 4 | Oberweis Micro-Cap | 1.64% | 1.3M | $9.3M | +114,800 (+9.9%) | June 30, 2026 |
| 5 | State Street® SPDR® S&P® PhrmctlsETF | 1.10% | 854K | $6.2M | −10,618 (−1.2%) | September 30, 2026 |
| 6 | Fidelity Small Cap Index | 1.05% | 817K | $5.9M | +7,041 (+0.9%) | July 31, 2026 |
| 7 | iShares Russell 2000 Value ETF | 0.88% | 688K | $5.0M | +1,044 (+0.2%) | September 30, 2026 |
| 8 | Pacer US Small Cap Cash Cows 100 ETF | 0.86% | 674K | $4.9M | +1,515 (+0.2%) | September 30, 2026 |
| 9 | FTGF RY US SmCp Opp A USD Dis(A) | 0.79% | 612K | $4.4M | −9,006 (−1.4%) | August 31, 2026 |
| 10 | Royce Small-Cap Opportunity Invmt | 0.73% | 567K | $4.1M | +150,003 (+36.0%) | June 30, 2026 |
| 11 | Royce Small-Cap Fund Invmt | 0.72% | 563K | $4.1M | −40,772 (−6.8%) | June 30, 2026 |
| 12 | Vanguard Russell 2000 ETF | 0.55% | 429K | $3.1M | +9,846 (+2.4%) | August 31, 2026 |
| 13 | Fidelity Extended Market Index | 0.47% | 365K | $2.7M | −1,162 (−0.3%) | August 31, 2026 |
| 14 | Schwab US Small-Cap ETF™ | 0.44% | 345K | $2.5M | +225 (+0.1%) | September 30, 2026 |
| 15 | First Trust Dow Jones Sel MicroCap ETF | 0.37% | 287K | $2.1M | — | September 30, 2026 |
| 16 | EA Bridgeway Omni Small-Cap Value ETF | 0.34% | 268K | $1.9M | — | September 30, 2026 |
| 17 | Royce Capital Small-Cap Inv | 0.31% | 245K | $1.8M | −39,617 (−13.9%) | June 30, 2026 |
| 18 | iShares US Pharmaceuticals ETF | 0.31% | 241K | $1.8M | +743 (+0.3%) | September 30, 2026 |
| 19 | iShares Micro-Cap ETF | 0.30% | 235K | $1.7M | −1,622 (−0.7%) | September 30, 2026 |
| 20 | Avantis® U.S. Small Cap Value Instl | 0.29% | 226K | $1.6M | +9,903 (+4.6%) | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
CRMD insider transactions
latest 9| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-30 | Alan W Dunton | Sell | $13.00 | 20,000 | $260,000 |
| 2025-12-18 | Joseph Todisco | Sell | $12.00 | 30,000 | $360,000 |
| 2025-12-09 | Steven W Lefkowitz | Sell | $11.88 | 40,000 | $475,200 |
| 2025-10-23 | Myron Kaplan | Buy | $11.02 | 25,000 | $275,500 |
| 2025-09-12 | Alan W Dunton | Sell | $13.13 | 10,000 | $131,300 |
| 2025-09-12 | Joseph Todisco | Sell | $13.00 | 50,000 | $650,000 |
| 2025-09-11 | Elizabeth Hurlburt | Sell | $13.08 | 41,121 | $537,863 |
| 2025-09-09 | Elizabeth Hurlburt | Sell | $13.51 | 12,876 | $173,955 |
| 2025-09-09 | Kaufman Beth Zelnick | Sell | $13.41 | 50,000 | $670,500 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
CRMD shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns CRMD
Institutional investors own 58.0% of CorMedix's shares and insiders 7.61%. The largest holder is BlackRock Inc with 8.11% of the shares (6.3M), as of June 30, 2026. Among the top 20 institutions, 15 added shares and 3 reduced their stake in the latest filings. Short interest is 20.05% of the float, or 17.97 days of average trading volume. The share count rose 1,863.1% since 2014.
Related: CRMD analyst forecast, CRMD key metrics. See the CRMD stock overview for the latest quote and news.
CRMD ownership FAQ
Who owns the most CorMedix stock?
The largest shareholders of CorMedix are BlackRock Inc (8.11%), Deep Track Capital, LP (8.05%), Vanguard Capital Management, LLC (4.02%), State Street Corp (2.97%), Royce & Associates, LP (2.79%).
What percentage of CorMedix is owned by institutions?
Institutions hold 58.0% of CorMedix's shares outstanding; insiders hold 7.61%.
Which funds own CorMedix?
The largest fund holders of CorMedix are Vanguard MStar Total Stk Mkt Idx Invest (2.86%), Avantis US Small Cap Value ETF (2.75%), iShares Russell 2000 ETF (2.50%), Oberweis Micro-Cap (1.64%), State Street® SPDR® S&P® PhrmctlsETF (1.10%).
What is CorMedix's short interest?
15.4M shares of CorMedix were sold short, 20.05% of the float; at the average daily volume it would take 17.97 days to cover.
Are insiders buying or selling CorMedix?
Of the latest 9 reported insider transactions in CorMedix (since September 9, 2025), 1 were purchases and 8 were sales.
How many shares of CorMedix are outstanding?
CorMedix has 77.9M shares outstanding, of which 65.9M are in the public float.